Bristol-Myers Squibb filed Form 13F with the Securities and Exchange Commission on August 25, 2026.

The entities involved

• Bristol-Myers Squibb →

  American pharmaceutical company

  • Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
  • FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
• Securities and Exchange Commission →

  government agency of the Philippines

  • BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Mon 16:42
  • Filing required regarding institutional holdings for Schwab Emerging Markets Equity ETF and Waterford Advisors LLC with the SEC.Mon 16:38

Related events

• Hello Group Inc. filed Form 13F with the SEC and is listed on the NASDAQ exchange.Sep 9
• AMN Healthcare Services Inc filed a required Form 13F regarding its company shares with the SEC.Aug 18
• flyExclusive, Inc. filed its Form 10-Q with the Securities and Exchange Commission.Jun 7
• Simon Property Group filed a Form 13F with the Securities and Exchange Commission.Sep 10
• Grainger filed a Form 13F with the Securities and Exchange Commission on August 17, 2026.Aug 17